Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Strike Over Teva Firings Shuts Israel Bourse, Banks, Airport - Bloomberg
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Opioid crisis: 4 pharmaceutical companies accused in the opioid epidemic reach a $260 million settlement just before trial | CNN
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva closes in on Allergan's generics unit
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva's job-cut tally could touch 10K: report | FiercePharma
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - BNN Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Wins Appeal That Upholds Three Patents for Migraine Drug
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug
